Genelux announces proposed public offering
Source: SeekingAlpha
2026-01-07 16:12:20 ET
More on Genelux
- Genelux: An Oncolytic Virus Player About To Cross The Phase 3 Finish Line, But On Shaky Ground
- Seeking Alpha’s Quant Rating on Genelux
- Historical earnings data for Genelux
- Financial information for Genelux
Read the full article on Seeking Alpha
For further details see:
Genelux announces proposed public offering
Genelux Corporation
NASDAQ: GNLX
GNLX Trading
7.05% G/L:
$2.8262 Last:
46,675 Volume:
$2.67 Open:
GNLX Latest News
January 12, 2026 04:00:00 pm
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
January 08, 2026 09:13:39 am
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
GNLX Stock Data
$92,073,203
34,698,662
0.72%
28
N/A
Biotechnology & Life Sciences
Healthcare
US
Westlake Village
